Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4XJR

The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed

Summary for 4XJR
Entry DOI10.2210/pdb4xjr/pdb
Related4XJQ
DescriptorHemagglutinin-neuraminidase, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, beta-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (9 entities in total)
Functional Keywordshydrolase, human parainfluenza virus 3, haemagglutinin-neuraminidase, sialidase mechanism
Biological sourceHuman parainfluenza virus 3
Total number of polymer chains2
Total formula weight104225.56
Authors
Dirr, L.,El-Deeb, I.,Guillon, P.,Carroux, C.,Chavas, L.,von Itzstein, M. (deposition date: 2015-01-08, release date: 2015-02-11, Last modification date: 2024-11-06)
Primary citationDirr, L.,El-Deeb, I.M.,Guillon, P.,Carroux, C.J.,Chavas, L.M.,von Itzstein, M.
The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed.
Angew.Chem.Int.Ed.Engl., 54:2936-2940, 2015
Cited by
PubMed Abstract: Human parainfluenza virus type 3 (hPIV-3) is one of the leading causes for lower respiratory tract disease in children, with neither an approved antiviral drug nor vaccine available to date. Understanding the catalytic mechanism of human parainfluenza virus haemagglutinin-neuraminidase (HN) protein is key to the design of specific inhibitors against this virus. Herein, we used (1) H NMR spectroscopy, X-ray crystallography, and virological assays to study the catalytic mechanism of the HN enzyme activity and have identified the conserved Tyr530 as a key amino acid involved in catalysis. A novel 2,3-difluorosialic acid derivative showed prolonged enzyme inhibition and was found to react and form a covalent bond with Tyr530. Furthermore, the novel derivative exhibited enhanced potency in virus blockade assays relative to its Neu2en analogue. These outcomes open the door for a new generation of potent inhibitors against hPIV-3 HN.
PubMed: 25676091
DOI: 10.1002/anie.201412243
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3 Å)
Structure validation

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon